These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7743310)

  • 1. A radical view of the stomach: the role of oxygen-derived free radicals and anti-oxidants in gastroduodenal disease.
    Phull PS; Green CJ; Jacyna MR
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):265-74. PubMed ID: 7743310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Helicobacter pylori and gastroduodenal disease].
    Vallot T
    Rev Prat; 1994 Apr; 44(7):894-9. PubMed ID: 7939299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of thrombin-activatable fibrinolysis inhibitor in Helicobacter pylori-associated gastroduodenal disease.
    Ikeda A; Gabazza EC; Morser J; Imoto I; Kuroda M; D'Alessandro-Gabazza CN; Hara K; Ruiz DB; Bernabe PG; Katsurahara M; Toda M; Kobayashi Y; Yano Y; Sumida Y; Suzuki K; Taguchi O; Takei Y
    Helicobacter; 2009 Apr; 14(2):147-55. PubMed ID: 19298343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of free radicals in inflammatory states, ulceration, and ulcers of the stomach and duodenum].
    Sieroń A; Kawczyk-Krupka A; Gadowska-Cicha A
    Pol Merkur Lekarski; 2001 Feb; 10(56):113-6. PubMed ID: 11320577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
    Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
    Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oxygen metabolism disturbances in the pathogenesis of gastric and duodenal diseases].
    Swiatkowski M; Budzyński J; Kłopocka M; Suppan K
    Przegl Lek; 1999; 56(3):220-6. PubMed ID: 10442013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between interleukin-1 gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in a Chinese population.
    Li C; Xia HH; Xie W; Hu Z; Ye M; Li J; Cheng H; Zhang X; Xia B
    J Gastroenterol Hepatol; 2007 Feb; 22(2):234-9. PubMed ID: 17295877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II)].
    Sahnoun Z; Jamoussi K; Zeghal KM
    Therapie; 1998; 53(4):315-39. PubMed ID: 9806002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer.
    Wu MS; Chen CJ; Lin JT
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1878-82. PubMed ID: 16103430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways, mediators and mechanisms of gastroduodenal mucosal injury.
    Szabo S; Nagy L
    Acta Physiol Hung; 1992; 80(1-4):9-21. PubMed ID: 1345211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic identification of biomarkers related to Helicobacter pylori-associated gastroduodenal disease: challenges and opportunities.
    Wu MS; Chow LP; Lin JT; Chiou SH
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1657-61. PubMed ID: 19120858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen metabolites and upper gastrointestinal diseases.
    Kountouras J; Chatzopoulos D; Zavos C
    Hepatogastroenterology; 2001; 48(39):743-51. PubMed ID: 11462918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
    Feldman M; Cryer B; Mallat D; Go MF
    Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between Helicobacter pylori, diet, and genetic polymorphisms as related to non-cancer diseases.
    Izzotti A; Durando P; Ansaldi F; Gianiorio F; Pulliero A
    Mutat Res; 2009 Jul; 667(1-2):142-57. PubMed ID: 19563929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A threshold concept for cancer therapy.
    Kong Q; Beel JA; Lillehei KO
    Med Hypotheses; 2000 Jul; 55(1):29-35. PubMed ID: 11021322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
    Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori-associated gastroduodenal disease in childhood.
    Blecker U
    South Med J; 1997 Jun; 90(6):570-6; quiz 577. PubMed ID: 9191731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Geographic and socioeconomic factors in the orientation of gastroduodenal pathology associated with Helicobacter pylori infection].
    León-Barúa R
    Acta Gastroenterol Latinoam; 2000; 30(5):491-6. PubMed ID: 11144944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessment of a free radical theory of cancer with emphasis on ultraviolet carcinogenesis.
    Black HS
    Integr Cancer Ther; 2004 Dec; 3(4):279-93. PubMed ID: 15523099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.